Olubusola B Oluwole1, Robert B Noll2, Daniel G Winger3, Olu Akinyanju4, Enrico M Novelli5. 1. School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. 2. Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania. 3. Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania. 4. Sickle Cell Foundation Nigeria, Lagos, Nigeria. 5. Division of Hematology/Oncology, Department of Medicine, Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania. noveex@upmc.edu.
Abstract
BACKGROUND: Cognitive impairment is a major neurological complication of sickle cell anemia (SCA) in the United States, but there are limited studies of cognitive impairment in Nigeria, the country with the highest SCA burden. We hypothesized that children from Nigeria with SCA have worse cognitive functioning than comparison children and explored the association between lower cognitive functioning and key laboratory demographic and socioeconomic variables among children with SCA. PROCEDURE: We conducted a cross-sectional survey, supplemented by anthropomorphic and laboratory data, among a convenience sample of children from Nigeria with and without SCA. We administered the Wechsler Intelligence Scale for Children, Version IV. Our primary outcome measures included (1) estimated IQ (Est. IQ), (2) working memory (WM), and (3) processing speed (PS). RESULTS: The sample included 56 children with SCA (mean age 9.20 [SD 2.75], 46.43% girls) and 44 comparison children (mean age 9.41 [SD 2.49], 40.91% girls). Children with SCA performed worse on Est. IQ (84.58 vs. 96.10, P = 0.006) and PS (86.69 vs 96.91, P = 0.009) than comparison children. There was no significant difference in WM between both groups. Factors associated with lower Est. IQ and PS among children with SCA included age, maternal education, weight-for-age Z scores, and height-for age Z scores. CONCLUSION: In this small sample of children from Nigeria, we found worse cognitive functioning in children with SCA than in comparison children, and that sociodemographic and anthropomorphic factors were correlated with cognitive functioning.
BACKGROUND:Cognitive impairment is a major neurological complication of sickle cell anemia (SCA) in the United States, but there are limited studies of cognitive impairment in Nigeria, the country with the highest SCA burden. We hypothesized that children from Nigeria with SCA have worse cognitive functioning than comparison children and explored the association between lower cognitive functioning and key laboratory demographic and socioeconomic variables among children with SCA. PROCEDURE: We conducted a cross-sectional survey, supplemented by anthropomorphic and laboratory data, among a convenience sample of children from Nigeria with and without SCA. We administered the Wechsler Intelligence Scale for Children, Version IV. Our primary outcome measures included (1) estimated IQ (Est. IQ), (2) working memory (WM), and (3) processing speed (PS). RESULTS: The sample included 56 children with SCA (mean age 9.20 [SD 2.75], 46.43% girls) and 44 comparison children (mean age 9.41 [SD 2.49], 40.91% girls). Children with SCA performed worse on Est. IQ (84.58 vs. 96.10, P = 0.006) and PS (86.69 vs 96.91, P = 0.009) than comparison children. There was no significant difference in WM between both groups. Factors associated with lower Est. IQ and PS among children with SCA included age, maternal education, weight-for-age Z scores, and height-for age Z scores. CONCLUSION: In this small sample of children from Nigeria, we found worse cognitive functioning in children with SCA than in comparison children, and that sociodemographic and anthropomorphic factors were correlated with cognitive functioning.
Authors: F D Armstrong; R J Thompson; W Wang; R Zimmerman; C H Pegelow; S Miller; F Moser; J Bello; A Hurtig; K Vass Journal: Pediatrics Date: 1996-06 Impact factor: 7.124
Authors: Robert B Noll; Jennifer Reiter-Purtill; Kathryn Vannatta; Cynthia A Gerhardt; Amy Short Journal: Child Neuropsychol Date: 2007-03 Impact factor: 2.500
Authors: Channa T Hijmans; Karin Fijnvandraat; Martha A Grootenhuis; Nan van Geloven; Harriët Heijboer; Marjolein Peters; Jaap Oosterlaan Journal: Pediatr Blood Cancer Date: 2010-12-15 Impact factor: 3.167
Authors: Enrico M Novelli; James B Hittner; Gregory C Davenport; Collins Ouma; Tom Were; Stephen Obaro; Sandra Kaplan; John M Ong'echa; Douglas J Perkins Journal: Br J Haematol Date: 2010-04-16 Impact factor: 6.998
Authors: Kemar V Prussien; Auwal Salihu; Shehu U Abdullahi; Najibah A Galadanci; Khadija Bulama; Raymond O Belonwu; Fenella J Kirkham; Janet Yarboi; Heather Bemis; Michael R DeBaun; Bruce E Compas Journal: Child Neuropsychol Date: 2018-10-01 Impact factor: 2.500
Authors: Gerard T Portela; Meryl A Butters; Maria M Brooks; Leticia Candra; Caterina Rosano; Enrico M Novelli Journal: Am J Hematol Date: 2022-07-01 Impact factor: 13.265
Authors: Hanne Stotesbury; Fenella J Kirkham; Melanie Kölbel; Philippa Balfour; Jonathan D Clayden; Sati Sahota; Simrat Sakaria; Dawn E Saunders; Jo Howard; Rachel Kesse-Adu; Baba Inusa; Maria Pelidis; Subarna Chakravorty; David C Rees; Moji Awogbade; Olu Wilkey; Mark Layton; Christopher A Clark; Jamie M Kawadler Journal: Neurology Date: 2018-05-11 Impact factor: 9.910
Authors: Nancy S Green; Deogratias Munube; Paul Bangirana; Linda Rosset Buluma; Bridget Kebirungi; Robert Opoka; Ezekiel Mupere; Philip Kasirye; Sarah Kiguli; Annet Birabwa; Michael S Kawooya; Samson K Lubowa; Rogers Sekibira; Edwards Kayongo; Heather Hume; Mitchell Elkind; Weixin Peng; Gen Li; Caterina Rosano; Philip LaRussa; Frank J Minja; Amelia Boehme; Richard Idro Journal: BMC Pediatr Date: 2019-10-25 Impact factor: 2.125